Stay updated on Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T19:46:58.000Z thumbnail image
  3. Check
    44 days ago
    Change Detected
    Summary
    - Revision label updated from v3.4.1 to v3.4.2. No substantive content changes to the page.
    Difference
    0.0%
    Check dated 2026-02-12T02:14:45.000Z thumbnail image
  4. Check
    51 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1 with no visible changes to core content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:30:43.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Show glossary added; minor capitalization changes to QC-related labels; and the revision number updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T21:41:41.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was introduced, replacing the previous v3.3.3; this appears to be a minor site version update with no changes to the study details, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:29:23.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Locations section expanded with new site locations across the United States, Canada, and Europe. The HHS Vulnerability Disclosure entry was removed.
    Difference
    2%
    Check dated 2025-12-23T22:35:29.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.